NCT05703750 2023-05-31
Impact of Clinical Evident Portal Hypertension on HCC With TACE (CHANCE-CHESS 2301)
Zhongda Hospital
Unknown
Clinical Trials
12 trialsNCT02192671 2022-01-18
HR-HCC/PHT
Guangxi Medical University
Phase 3 Unknown
NCT05141617 2021-12-02
Management of Oxaliplatin-related Gastroesophageal Variceal Bleeding
Shanghai Zhongshan Hospital
Phase NA Unknown
NCT04640116 2020-12-19
TIPS Combined With Microwave Ablation in HCC Patients With Refractory Ascites
Sun Yat-sen University
Phase NA Unknown
NCT04524650 2020-08-28
Early Diagnosis of Oxaliplatin-induced Portal Hypertension
Shanghai Zhongshan Hospital
Unknown
NCT04525768 2020-08-25
Gastroesophageal Varices in Cavernoma
Shanghai Zhongshan Hospital
Unknown
NCT04524676 2020-08-24
Oxaliplatin-induced Portal Hypertension
Shanghai Zhongshan Hospital
Phase NA Unknown
NCT01451658 2019-09-04
A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol (S-HCC)
Taipei Veterans General Hospital, Taiwan
Phase 4 Unknown
NCT01970748 2019-08-30
P-HCC
Taipei Veterans General Hospital, Taiwan
Phase 4 Unknown
NCT02145013 2018-02-12
Portal Hypertension and Liver Resection in Patients With Hepatocellular Carcinoma
Henri Mondor University Hospital
Unknown
NCT02305914 2015-05-22
FSCAP
The First Affiliated Hospital of Nanchang University
Unknown
NCT01298284 2011-06-15
A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol
Taipei Veterans General Hospital, Taiwan
Phase 4 Unknown